FDA Inspection 1257449 — Changzhou Maokang Medical Products Co., Ltd
The FDA completed an inspection of Changzhou Maokang Medical Products Co., Ltd on Nov 29, 2024 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 29, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)